ARCHIVES

Panel Calls For New Office, Advisory Groups To Oversee NCI’s Translational Research.

This article is from The Cancer Letter archive.

Vol. 33 No. 24 | June 22, 2007

Download PDF Visit The Full Archive

Related Articles

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

Zubrod To Retire as Miami Director; Baker Succeeds Brennan As Director Of Detroit Center

January 29, 1988

Alan Rabson Outlasts Them All, Even His Bosses, As DCBD Chief

January 15, 1982